Genetically engineered bacterium for the production of isobutylene

US10316337B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10316337-B2
Application numberUS-201815922451-A
CountryUS
Kind codeB2
Filing dateMar 15, 2018
Priority dateOct 13, 2015
Publication dateJun 11, 2019
Grant dateJun 11, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a genetically engineered bacterium having an enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate and an enzyme that converts 3-hydroxyisovalerate to isobutylene. Typically, the bacterium is capable of producing isobutylene from a gaseous substrate containing CO, CO2, and/or H2, such as syngas or an industrial waste gas.

First claim

Opening claim text (preview).

The invention claimed is: 1. A genetically engineered C1-fixing bacterium comprising: (a) an enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate and (b) an enzyme that converts 3-hydroxyisovalerate to isobutylene, wherein at least one of the enzymes is exogenous to the bacterium. 2. The bacterium of claim 1 , wherein the enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate is thioesterase (EC 3.1.2.20), phosphate butyryltransferase (EC 2.3.1.19) and butyrate kinase (EC 2.7.2.7), or CoA-transferase (EC 2.8.3.9). 3. The bacterium of claim 1 , wherein the enzyme that converts 3-hydroxyisovalerate to isobutylene is hydroxyisovalerate phosphorylase/decarboxylase or mevalonate diphosphate decarboxylase (EC 4.1.1.33). 4. The bacterium of claim 1 , wherein the bacterium further comprises one or more enzymes selected from the group consisting of citramalate synthase (EC 2.3.1.182), 3-isopropylmalate dehydratase (EC 4.2.1.35), 3-isopropylmalate dehydrogenase (EC 1.1.1.85), acetolactate synthase (EC 2.2.1.6), ketol-acid reductoisomerase (EC 1.1.1.86), dihydroxyacid dehydratase (EC 4.2.1.9), ketoisovalerate oxidoreductase (EC 1.2.7.7), 2-methylbutanoyl-CoA dehydrogenase (EC 1.3.99.12), crotonase/3-hydroxybutyryl-CoA dehydratase (EC 4.2.1.55), crotonyl-CoA carboxylase-reductase (EC 1.3.1.86), crotonyl-CoA reductase (EC 1.3.1.44), 3-hydroxypropionyl-CoA dehydratase (EC 4.2.1.116), enoyl-CoA hydratase (4.2.1.17), thiolase (EC 2.3.1.9), thioesterase (EC 3.1.2.20), phosphate butyryltransferase (EC 2.3.1.19), butyrate kinase (EC 2.7.2.7), or CoA-transferase (EC 2.8.3.9), acetoacetate decarboxylase (EC 4.1.1.4), alpha-ketoisovalerate decarboxylase (EC 4.1.1.74), 3-hydroxyisovaleryl-CoA synthase, hydroxymethylglutaryl-CoA synthase (EC 2.3.3.10), 3-hydroxybutyryl-CoA dehydratase (EC 4.2.1.55), enoyl-CoA hydratase (EC 4.2.1.17), methylcrotonyl-CoA decarboxylase, and methylcrotonoyl-CoA carboxylase (EC 6.4.1.4). 5. The bacterium of claim 1 , wherein the bacterium is an anaerobe, an acetogen, an ethanologen, a carboxydotroph, or a methanotroph. 6. The bacterium of claim 1 , wherein the bacterium is derived from a parental bacterium selected from the group consisting of Acetobacterium woodii, Alkalibaculum bacchii, Blautia product, Butyribacterium methylotrophicum, Clostridium aceticum, Clostridium autoethanogenum, Clostridium carboxidivorans, Clostridium coskatii, Clostridium drakei, Clostridium formicoaceticum, Clostridium ljungdahlii, Clostridium magnum, Clostridium ragsdalei, Clostridium scatologenes, Eubacterium limosum, Moorella thermautotrophica, Moorella thermoacetica, Oxobacter pfennigii, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides , and Thermoanaerobacter kiuvi. 7. A method of producing isobutylene comprising culturing the bacterium of claim 1 in the presence of a substrate, whereby the bacterium produces isobutylene. 8. The method of claim 7 , wherein the substrate is a gaseous substrate comprising one or more of CO, CO 2 , CH 4 , and H 2 . 9. The method of claim 7 , wherein the substrate comprises syngas or industrial waste gas. 10. The method of claim 7 , wherein the bacterium is an anaerobe, an acetogen, an ethanologen, a carboxydotroph, or a methanotroph. 11. The method of claim 7 , wherein the bacterium is derived from a parental bacterium selected from the group consisting of Acetobacterium woodii, Alkalibaculum bacchii, Blautia product, Butyribacterium methylotrophicum, Clostridium aceticum, Clostridium autoethanogenum, Clostridium carboxidivorans, Clostridium coskatii, Clostridium drakei, Clostridium formicoaceticum, Clostridium ljungdahlii, Clostridium magnum, Clostridium ragsdalei, Clostridium scatologenes, Eubacterium limosum, Moorella thermautotrophica, Moorella thermoacetica, Oxobacter pfennigii, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides , and Thermoanaerobacter kiuvi.

Assignees

Inventors

Classifications

  • Alcohol dehydrogenase (NADP+) (1.1.1.2), i.e. aldehyde reductase · CPC title

  • polyhydric · CPC title

  • Butyrate kinase (2.7.2.7) · CPC title

  • Unsaturated compounds, i.e. alkenes, alkynes or allenes · CPC title

  • acyclic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10316337B2 cover?
The invention relates to a genetically engineered bacterium having an enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate and an enzyme that converts 3-hydroxyisovalerate to isobutylene. Typically, the bacterium is capable of producing isobutylene from a gaseous substrate containing CO, CO2, and/or H2, such as syngas or an industrial waste gas.
Who is the assignee on this patent?
Lanzatech New Zealand Ltd
What technology area does this patent fall under?
Primary CPC classification C12N15/74. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).